| TME | Tumor microenvironment |
| CAFs | Cancer-associated fibroblasts |
| TAMs | Tumor-associated macrophage |
| ASCs | Adipose stem cells |
| CAAs | Cancer-associated adipocytes |
| ECM | Extracellular matrix |
| CHAT | Cancer Hallmarks Analytics Tool |
| CM | Conditioned medium |
| ILC | Invasive lobular breast carcinom |
| IDC | Invasive ductal breast carcinoma |
| MLD | Mixed lobular & ductal breast carcinoma |
| PAI-1/SERPINE1 | Plasminogen activator inhibitor 1 |
| OBR/LEPR | Leptin receptor |
| IF | Immunofluorescence |
| IHC | Immunohistochemistry |
| WB | Western blot |
| OS | Overall survival |
| DMFS | Distance metastasis free survival |
| PS | Postsurgical survival |
| RFS | Relapse free survival |
| EMT | Epithelial-mesenchymal transition |
| F-actin | Filamentous actin |
| TNBC | Triple negative breast cancer |
| TFs | Transcription factors |
| OXPHOS | Oxidative phosphorylation |
| miRNAs | MicroRNAs |
| NSCLC | Non-small-cell lung cancer |